19 May 2022 14:00
19 May 2022
Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Issue of new shares under the Share Incentive Plan and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it allotted a total of 3,955 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") on 18 May 2022 following the purchase of 3,955 Ordinary Shares in aggregate by a number of employees under the Company's Share Incentive Plan ("SIP").
Application has been made to the London Stock Exchange for the 3,955 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 25 May 2022.
After Admission, the total number of Ordinary Shares in issue will be 293,753,784 and the total number of voting rights will therefore be 293,753,784. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc | 01629 699 100 |
Ben Dorks, Chief Executive Officer | |
Emma Hayes, Chief Financial Officer
| |
Canaccord Genuity Limited (Nomad) | 020 7523 8000 |
Simon Bridges |
|
Georgina McCooke |
|
|
|
finnCap Limited | 020 7220 0500 |
Henrik Persson/James Thompson | |
Alice Lane
| |
|
|
Numis Securities Limited | 0207 260 1267 |
Simon Willis |
|
Joshua Hughes |
|
|
|
FTI Consulting | 020 3727 1000 |
Jamie Ricketts | ideagen@fticonsulting.com |
Dwight Burden | |
Valerija Cymbal |
About Ideagen plc
Ideagen's software helps companies comply with regulation and manage risk.
Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance.
More than 8,000 customers use Ideagen's software, including leading accounting and pharmaceutical firms.
Ideagen has a track record of 12 years of profitable growth and strong cash generation with high levels of recurring revenues (representing an expected 86% of total revenues for the year ended 30 April 2022).
Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, Aggreko, Bank of New York and Johnson Matthey.
Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, USA, Middle East and South East Asia. For further information please visit www.ideagen.com.